Working… Menu
Trial record 1 of 1 for:    lb-100 small cell
Previous Study | Return to List | Next Study

LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04560972
Recruitment Status : Recruiting
First Posted : September 23, 2020
Last Update Posted : March 15, 2021
National Cancer Institute (NCI)
Information provided by (Responsible Party):
City of Hope Medical Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 8, 2022
Estimated Study Completion Date : August 8, 2022